
### [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610)
**Label:** Oropharyngeal Undifferentiated Carcinoma

**Subclasses:** [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39739](http://purl.obolibrary.org/obo/NCIT_C39739) (Negative Peripheral Blood))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39725](http://purl.obolibrary.org/obo/NCIT_C39725) (Immunodeficiency))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39721](http://purl.obolibrary.org/obo/NCIT_C39721) (Abundance of Small Lymphocytes))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39720](http://purl.obolibrary.org/obo/NCIT_C39720) (Classical Reed-Sternberg Cell))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39719](http://purl.obolibrary.org/obo/NCIT_C39719) (PDGFRalpha Protein Overexpression))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39718](http://purl.obolibrary.org/obo/NCIT_C39718) (PDGFRA Gene Mutation))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39717](http://purl.obolibrary.org/obo/NCIT_C39717) (MDM2 Gene Mutation))) 37.74%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression))) 37.74%


